Explore Tapestri Triomics, Mission Bio's single-cell platform measuring DNA, RNA, and protein from the same cell to reveal genotype-to-phenotype connections.

What to Expect Scientific sessions from leading voices in single-cell research Emerging applications in cancer, immunology, and cell therapy Insights in...

Discover the "Resolution Revolution" in oncology. Download the Single-Cell Sequencing Vol2 eBook to learn how single-cell DNA and multi-omics uncover hidden clonal architecture, identify therapy-resis...

Measurable residual disease (MRD) predicts relapse in AML and beyond. See how single-cell multiomics reveals which clones survive treatment, and why.

Learn how pairing Integrated DNA Technologies’ (IDT) rhAmpSeq™ System and Mission Bio’s Tapestri® enables deep single-cell characterization of CRISPR genome editing in primary T cells

Bring the Tapestri Platform in-house this May for just $99,000. Unlock single-cell DNA, RNA, and protein resolution at our lowest price ever. Offer ends May 31.

The use of CRISPR-Cas9 genome editing has been wildly successful in the cell & gene therapy space, but DNA double-strand breaks can trigger severe genotoxi...

Download the Tapestri® Cell & Gene Therapy flyer to see how single-cell multiomics evaluates CQAs like vector copy number, gene editing co-occurrence, and genotoxicity to meet FDA CMC guidelines.

This study uses single-cell DNA sequencing to analyze genomic evolution in pancreatic cancer using a cohort of multiregionally and longitudinally sampled patients’ tissues across various clinical cont...

In this webinar, Stefan Radtke will discuss the development of new high-throughput single-cell readouts for precise and comprehensive tracking of gene editing outcomes after autologous hematopoietic s...

Discover how single-cell CXCR4 biomarker stratification revealed hidden clinical utility for Motixafortide in AML patients, overcoming the limitations of bulk sequencing.

Learn how Tapestri enables comprehensive single-cell sequencing of DNA, RNA, and proteins to study cancer, clonal mosaicism, and cell therapies with precision.

[Happening This Week] This week Daniele Canarutto, M.D., Ph.D. will present how single-cell DNA sequencing was used to rigorously validate genomic editing outcomes for their CRISPR-based therapy targe...

Hyper-IgM 1 (HIGM1) is an X-linked combined immunodeficiency that is caused by a CD40LG mutation that impairs communication between active CD4+ T cells and...

From genotype to phenotype at single-cell resolution. See how targeted DNA + RNA analysis helps researchers connect variants to cellular function and uncover new biological insight.

Clonal heterogeneity in acute myeloid leukemia (AML) can drive drug resistance because different clones may respond variably to treatments. Studying the ev...

To overcome the limitations of bulk analysis in genome editing in applications like therapeutics, which can mask critical off-target events that compromise...

Mission Bio launches the Tapestri DNA + RNA Assay, the first single-cell platform to link mutations with gene expression, advancing precision medicine and therapy development.

De-risk drug development and cell & gene therapies with targeted single-cell multi-omics linking genomics with gene expression data leveraging Mission Bio’s Pharma Assay Development (PAD) services.

Background Cutaneous squamous cell carcinoma (CSCC) is a prevalent skin cancer with aggressive progression that poses significant challenges, especially in metastatic cases. Single-cell DNA sequencing...

YouTube video by Mission Bio

Epigenetic barcoding incorporating Tapestri unlocks high-throughput single-cell lineage tracing of clonality with or without mutation drivers, a previously invisible precursor to cancer development EP...